{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:31:10Z","timestamp":1787596270723,"version":"build-2736575974"},"reference-count":121,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Hemorrhage is a leading cause of preventable death following trauma, and numerous randomized controlled trials (RCTs) have evaluated hemostatic interventions. However, inconsistency in outcome reporting hinders evidence synthesis and guideline development. We systematically reviewed outcomes reported in RCTs of hemostatic interventions for trauma to identify variability in outcome domains, definitions, and measurement time points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Following the PRISMA guidelines, we searched Ovid MEDLINE, EMBASE, and CENTRAL from inception to May 2025. Eligible studies were RCTs evaluating hemostatic interventions in trauma patients of any age. Two reviewers independently screened records, extracted data, and categorized outcomes into domains. Data were summarized descriptively. The review was prospectively registered with PROSPERO (ID:).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 6,752 records screened, 110 studies were included (2005\u20132025). Most trials were parallel-group RCTs (88.2%), with a median sample size of 314 participants (IQR, 99\u2013680). Tranexamic acid was the most common intervention studied (39.1%). Mortality was reported as the primary outcome in 56.4% studies, most frequently assessed at 28 to 30 days. Of all trials, 36.4% reported a statistically significant difference in the primary outcome. Patient-centered outcomes were infrequently assessed: quality of life (7.3%), functional status (2.7%), and disability (25.5%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      Outcome reporting in RCTs of hemostatic interventions for trauma remains highly heterogeneous. Mortality is the most common primary endpoint, whereas patient-centered outcomes are rarely reported. Consensus on a Core Outcome Set with patient input would standardize reporting, improve comparability, and strengthen evidence for future trauma care research and policy, while also ensuring outcomes reflect patient priorities. (\n                      <jats:italic toggle=\"yes\">J Trauma Acute Care Surg<\/jats:italic>\n                      . 2026;101: 519\u2013530. Copyright \u00a9 2026 Wolters Kluwer Health, LLC. All rights reserved.)\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>Systematic Review\/Meta-Analysis; Level I.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ta.0000000000004989","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:00:09Z","timestamp":1781553609000},"page":"519-530","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes of hemostatic interventions in patients with traumatic injury: A systematic review of randomized controlled trials"],"prefix":"10.1097","volume":"101","author":[{"given":"James","family":"Winearls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbie","family":"McPaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Reade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-7185","authenticated-orcid":false,"given":"Zoe K.","family":"McQuilten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"suppl 5","key":"R1-20260824","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/cc3779","article-title":"The epidemiology and modern management of traumatic hemorrhage: US and international perspectives","volume":"9","author":"Kauvar","year":"2005","journal-title":"Crit Care"},{"issue":"7","key":"R2-20260824","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00268-007-9087-2","article-title":"Epidemiology of urban trauma deaths: a comprehensive reassessment 10 years later","volume":"31","author":"Cothren","year":"2007","journal-title":"World J Surg."},{"issue":"18","key":"R3-20260824","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMra1109343","article-title":"Injuries","volume":"368","author":"Norton","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"R4-20260824","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/bjs.10052","article-title":"Mortality from trauma haemorrhage and opportunities for improvement in transfusion practice","volume":"103","author":"Stanworth","year":"2016","journal-title":"Br J Surg"},{"issue":"1","key":"R5-20260824","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: sixthedition","volume":"27","author":"Rossaint","year":"2023","journal-title":"Crit Care"},{"issue":"1","key":"R6-20260824","doi-asserted-by":"crossref","first-page":"100849","DOI":"10.1016\/j.cpsurg.2020.100849","article-title":"The impact of trauma systems on patient outcomes","volume":"58","author":"Choi","year":"2021","journal-title":"Curr Probl Surg."},{"issue":"1","key":"R7-20260824","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fifthedition","volume":"23","author":"Spahn","year":"2019","journal-title":"Crit Care"},{"issue":"9734","key":"R8-20260824","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial","volume":"376","year":"2010","journal-title":"Lancet"},{"issue":"10210","key":"R9-20260824","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"R10-20260824","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"issue":"12","key":"R11-20260824","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1503\/cmaj.121986","article-title":"Effect of a fixed-ratio (1:1:1) transfusion protocol versuslaboratory-results guided transfusion in patients with severe trauma: a randomized feasibility trial","volume":"185","author":"Nascimento","year":"2013","journal-title":"CMAJ"},{"issue":"10","key":"R12-20260824","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurological outcomes in patients with moderate or severe traumatic brain injury: the PATCH trial","volume":"324","author":"Rowell","year":"2020","journal-title":"JAMA"},{"key":"R13-20260824","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"issue":"Suppl 2","key":"R14-20260824","first-page":"S1","article-title":"Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding","volume":"91","author":"Spinella","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"R15-20260824","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/SLA.0000000000004563","article-title":"Evidence-based and clinically relevant outcomes for hemorrhage control trauma trials","volume":"273","author":"Holcomb","year":"2021","journal-title":"Ann Surg"},{"key":"R16-20260824","first-page":"521","article-title":"Core outcome sets and trial reporting: current situation and future directions","volume":"16","author":"Clarke","year":"2015","journal-title":"Trials"},{"issue":"6","key":"R17-20260824","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/TA.0000000000003884","article-title":"Establishing a core outcome set for massive transfusion: an EAST modified Delphi consensus study","volume":"94","author":"Sherren","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"R18-20260824","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/TA.0000000000003546","article-title":"Core outcome measures for research in traumatic injury survivors: the NTRAP modified Delphi consensus study","volume":"92","author":"Herrera-Escobar","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"R21-20260824","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa2215457","article-title":"Prehospital tranexamic acid for severe trauma","volume":"389","author":"Gruen","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"R22-20260824","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.ajem.2018.02.018","article-title":"The effect of fibrinogen concentrate and fresh frozen plasma on the outcome of patients with acute traumatic coagulopathy: a quasi-experimental study","volume":"36","author":"Akbari","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"1","key":"R23-20260824","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/TA.0000000000002530","article-title":"Severity of hemorrhage and the survival benefit associated with plasma: results from a randomized prehospital plasma trial","volume":"88","author":"Anto","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"R24-20260824","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/TA.0000000000004276","article-title":"Outcomes of patients enrolled in a prospective and randomized trial based on gestalt assessment or ABC score","volume":"96","author":"Baird","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R25-20260824","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00134-020-06266-1","article-title":"Viscoelastic haemostatic assay-augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial","volume":"47","author":"Baksaas-Aasen","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"R26-20260824","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials","volume":"59","author":"Boffard","year":"2005","journal-title":"J Trauma"},{"issue":"Suppl 5","key":"R27-20260824","first-page":"240S","article-title":"The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage","volume":"49","author":"Boffard","year":"2009","journal-title":"Transfusion"},{"issue":"16","key":"R28-20260824","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2023.4080","article-title":"Efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion: the PROCOAG randomized clinical trial","volume":"329","author":"Bouzat","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"R30-20260824","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/TA.0000000000003767","article-title":"Effects of timing of prehospital tranexamic acid on outcomes after traumatic brain injury: subanalysis of a randomized controlled trial","volume":"94","author":"Brito","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R31-20260824","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41598-023-28422-5","article-title":"Evaluation of critical care burden following traumatic injury from two randomized controlled trials","volume":"13","author":"Campwala","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"R32-20260824","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00068-018-0974-z","article-title":"Benefits of tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients","volume":"45","author":"Chakroun-Walha","year":"2019","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"2","key":"R33-20260824","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TA.0000000000002263","article-title":"Earlier time to hemostasis is associated with decreased mortality and complications: results from the Pragmatic Randomized Optimal Platelet and Plasma Ratiotrial","volume":"87","author":"Chang","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"R34-20260824","first-page":"1524","article-title":"Quality of life after severe trauma: results from the global trauma trial with recombinant factor VII","volume":"70","author":"Christensen","year":"2011","journal-title":"J Trauma"},{"issue":"2","key":"R35-20260824","first-page":"344","article-title":"Global differences in causes, management, and survival after severe trauma: the recombinant activated factor VII phase 3 trauma trial","volume":"69","author":"Christensen","year":"2010","journal-title":"J Trauma"},{"issue":"1","key":"R36-20260824","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00068-020-01316-1","article-title":"Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial","volume":"47","year":"2021","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"4","key":"R37-20260824","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/SLA.0b013e3182a4ffa0","article-title":"Randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions","volume":"258","author":"Cotton","year":"2013","journal-title":"Ann Surg"},{"key":"R38-20260824","doi-asserted-by":"crossref","first-page":"d3795","DOI":"10.1136\/bmj.d3795","article-title":"Effect of tranexamic acid in traumatic brain injury: a nested randomized, placebo-controlled trial (CRASH-2 Intracranial Bleeding Study)","volume":"343","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"R39-20260824","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2352-3026(22)00040-0","article-title":"Resuscitation with blood products in trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomized, controlled, phase 3 trial","volume":"9","author":"Crombie","year":"2022","journal-title":"Lancet Haematol"},{"issue":"1","key":"R40-20260824","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13054-018-2086-x","article-title":"Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomized, double-blind, placebo-controlled pilot trial","volume":"22","author":"Curry","year":"2018","journal-title":"Crit Care"},{"issue":"1","key":"R41-20260824","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/bja\/aev134","article-title":"Early cryoprecipitate for major haemorrhage in trauma: a randomized controlled feasibility trial","volume":"115","author":"Curry","year":"2015","journal-title":"Br J Anaesth"},{"issue":"19","key":"R42-20260824","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.2023.21019","article-title":"Early and empirical high-dose cryoprecipitate for hemorrhage after traumatic injury: the CRYOSTAT-2 randomized clinical trial","volume":"330","author":"Davenport","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"R43-20260824","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/TA.0000000000003620","article-title":"Prehospital synergy: tranexamic acid and blood transfusion in patients at risk for hemorrhage","volume":"93","author":"Deeb","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"R44-20260824","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/XCS.0000000000000695","article-title":"Optimal prehospital crystalloid resuscitation volume in trauma patients at risk for hemorrhagic shock","volume":"237","author":"Deeb","year":"2023","journal-title":"J Am Coll Surg"},{"issue":"4","key":"R45-20260824","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/TA.0000000000003820","article-title":"Time to early resuscitative intervention association with mortality in trauma patients at risk for hemorrhage","volume":"94","author":"Deeb","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"key":"R46-20260824","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jss.2024.06.035","article-title":"The association between tranexamic acid and seizures in moderate or severe traumatic brain injury","volume":"301","author":"Deshpande","year":"2024","journal-title":"J Surg Res"},{"issue":"5","key":"R47-20260824","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TA.0000000000002932","article-title":"Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury","volume":"89","author":"Dixon","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"R48-20260824","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/TA.0000000000004122","article-title":"Association of fibrinolysis phenotype with patient outcomes following traumatic brain injury","volume":"96","author":"Durbin","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R49-20260824","first-page":"12","article-title":"Recombinant activated factor VII safety in trauma patients: results from the CONTROL trial","volume":"71","author":"Dutton","year":"2011","journal-title":"J Trauma"},{"issue":"4","key":"R50-20260824","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/1574887114666190620112829","article-title":"Intravenous tranexamic acid for subdural and epidural intracranial hemorrhage: randomized, double-blind, placebo-controlled trial","volume":"14","author":"Ebrahimi","year":"2019","journal-title":"Rev Recent Clin Trials"},{"issue":"4","key":"R51-20260824","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1007\/s00068-021-01848-0","article-title":"Efficacy and safety of the second in-hospital dose of tranexamic acid after receiving the prehospital dose: double-blind randomized controlled clinical trial in a level 1 trauma center","volume":"48","author":"El-Menyar","year":"2022","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"2","key":"R52-20260824","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.clineuro.2006.09.001","article-title":"The effect of fresh frozen plasma in severe closed head injury","volume":"109","author":"Etemadrezaie","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"R53-20260824","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/atr.atr_43_22","article-title":"The impact of tranexamic acid on brain contusion and intraparenchymal hemorrhage in patients with head injury","volume":"11","author":"Fakharian","year":"2022","journal-title":"Arch Trauma Res."},{"key":"R54-20260824","doi-asserted-by":"crossref","first-page":"e748","DOI":"10.1016\/j.wneu.2017.10.075","article-title":"Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury","volume":"109","author":"Fakharian","year":"2018","journal-title":"World Neurosurgery"},{"issue":"4","key":"R55-20260824","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/TA.0000000000001584","article-title":"Outcomes after concomitant traumatic brain injury and hemorrhagic shock: a secondary analysis from the Pragmatic, Randomized Optimal Platelets and Plasma Ratiostrial","volume":"83","author":"Galvagno","year":"2017","journal-title":"J Trauma Acute Care Surg."},{"issue":"3","key":"R56-20260824","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jth.13929","article-title":"French lyophilized plasma versus fresh frozen plasma for the initial management of trauma-induced coagulopathy: a randomized open-label trial","volume":"16","author":"Garrigue","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"6","key":"R57-20260824","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/SLA.0000000000001608","article-title":"Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional assays","volume":"263","author":"Gonzalez","year":"2016","journal-title":"Ann Surg."},{"issue":"5","key":"R58-20260824","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/TA.0000000000002816","article-title":"Characterization of unexpected survivors following a prehospital plasma randomized trial","volume":"89","author":"Gruen","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"R59-20260824","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/TA.0000000000003955","article-title":"Prehospital tranexamic acid is associated with a dose-dependent decrease in syndecan-1 after trauma: a secondary analysis of a prospective randomized trial","volume":"95","author":"Gruen","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"issue":"10","key":"R60-20260824","doi-asserted-by":"crossref","first-page":"e2016869","DOI":"10.1001\/jamanetworkopen.2020.16869","article-title":"Association of prehospital plasma with survival in patients with traumatic brain injury: a secondary analysis of the PAMPer cluster randomized clinical trial","volume":"3","author":"Gruen","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"R61-20260824","doi-asserted-by":"crossref","first-page":"e18987","DOI":"10.1371\/journal.pone.0018987","article-title":"Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial","volume":"6","author":"Guerriero","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"R62-20260824","first-page":"11","article-title":"Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a randomized, placebo-controlled trial","volume":"156","author":"Guyette","year":"2020","journal-title":"JAMA Surg"},{"issue":"2","key":"R63-20260824","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/SLA.0000000000003324","article-title":"Prehospital blood product and crystalloid resuscitation in the severely injured patient: a secondary analysis of the Prehospital Air Medical Plasma trial","volume":"273","author":"Guyette","year":"2021","journal-title":"Ann Surg"},{"issue":"1","key":"R64-20260824","doi-asserted-by":"crossref","first-page":"e000777","DOI":"10.1136\/tsaco-2021-000777","article-title":"Damage control laparotomy in trauma: a pilot randomized controlled trial.The DCL trial","volume":"6","author":"Harvin","year":"2021","journal-title":"Trauma Surg Acute Care Open"},{"issue":"1","key":"R65-20260824","doi-asserted-by":"crossref","first-page":"e23862","DOI":"10.5812\/traumamon.23862","article-title":"Celox-coated gauze for the treatment of civilian penetrating trauma: a randomized clinical trial","volume":"20","author":"Hatamabadi","year":"2015","journal-title":"Trauma Mon"},{"issue":"6","key":"R66-20260824","first-page":"1463","article-title":"Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage","volume":"68","author":"Hauser","year":"2010","journal-title":"J Trauma"},{"issue":"4","key":"R67-20260824","first-page":"104","article-title":"Effect of hemocoagulase on coagulation parameters, blood transfusion volume and bleeding volume in patients with severe traumatic fractures","volume":"19","author":"Zhao","year":"2023","journal-title":"Signa Vitae"},{"issue":"1","key":"R68-20260824","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40560-023-00682-3","article-title":"The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) trial: a cluster-randomized, crossover, non-inferiority multicenter trial of restrictive transfusion in trauma","volume":"11","author":"Hayakawa","year":"2023","journal-title":"J Intensive Care"},{"issue":"1","key":"R69-20260824","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/TA.0000000000004130","article-title":"TXA does not affect levels of TBI-related biomarkers in blunt TBI with ICH: a secondary analysis of the prehospital TXA for TBI trial","volume":"96","author":"Hoefer","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"issue":"17","key":"R70-20260824","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.3390\/jcm10173930","article-title":"First-line administration of fibrinogen concentrate in the bleeding trauma patient: searching for effective dosages and optimal post-treatment levels limiting massive transfusion- further results of the RETIC study","volume":"10","author":"Innerhofer","year":"2021","journal-title":"J Clin Med."},{"issue":"6","key":"R71-20260824","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","article-title":"Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, open-label randomised trial","volume":"4","author":"Innerhofer","year":"2017","journal-title":"Lancet Haematol."},{"issue":"19","key":"R72-20260824","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1001\/jama.2023.20850","article-title":"Emergency Department resuscitative endovascular balloon occlusion of the aorta in trauma patients with exsanguinating haemorrhage: the UK-REBOA randomized clinical trial","volume":"330","author":"Jansen","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"R73-20260824","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cjtee.2016.02.005","article-title":"The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial","volume":"20","author":"Jokar","year":"2017","journal-title":"Chin J Traumatol"},{"issue":"6","key":"R74-20260824","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.annemergmed.2018.09.033","article-title":"Older blood is associated with increased mortality and adverse events in massively transfused trauma patients: secondary analysis of the PROPPR trial","volume":"73","author":"Jones","year":"2019","journal-title":"Ann Emerg Med."},{"issue":"6","key":"R75-20260824","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1017\/S1049023X23006428","article-title":"Epidemiology of trauma-related hemorrhage and time to definitive care across North America: making the case for bleeding control education","volume":"38","author":"Jones","year":"2023","journal-title":"Prehosp Disaster Med."},{"issue":"7","key":"R76-20260824","doi-asserted-by":"crossref","first-page":"e2227220","DOI":"10.1001\/jamanetworkopen.2022.23619","article-title":"Prehospital lyophilized plasma transfusion for trauma-induced coagulopathy in patients at risk for hemorrhagic shock","volume":"5","author":"Jost","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"R77-20260824","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/cc4977","article-title":"Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding","volume":"10","author":"Klitgaard","year":"2006","journal-title":"Crit Care"},{"issue":"1","key":"R78-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13017-023-00530-7","article-title":"Association of initial lactate levels and red blood cell transfusion strategy with outcomes after severe trauma: a post hoc analysis of the RESTRIC trial","volume":"19","author":"Kosaki","year":"2024","journal-title":"World J Emerg Surg"},{"issue":"2","key":"R79-20260824","doi-asserted-by":"crossref","first-page":"e230421","DOI":"10.1001\/jamanetworkopen.2023.0421","article-title":"Use of Bayesian statistics to reanalyse data from the Pragmatic Randomized Optimal Platelet and Plasma Ratiostrial","volume":"6","author":"Lammers","year":"2023","journal-title":"JAMA Netw Open."},{"issue":"4","key":"R80-20260824","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.surg.2022.04.039","article-title":"Prehospital plasma is associated with survival principally in patients transferred from the scene of injury: a secondary analysis of the PAMPer trial","volume":"172","author":"Lewis","year":"2022","journal-title":"Surgery"},{"issue":"2","key":"R81-20260824","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.injury.2015.10.008","article-title":"Retroperitoneal packing or angioembolization for haemorrhage control of pelvic fractures: quasi-randomized clinical trial of 56 haemodynamically unstable patients with Injury Severity Score \u2265 33","volume":"47","author":"Li","year":"2016","journal-title":"Injury"},{"issue":"5","key":"R82-20260824","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/ALN.0000000000005183","article-title":"Correction of trauma-induced coagulopathy by goal-directed therapy: a secondary analysis of the ITACTIC trial","volume":"141","author":"Lindsay","year":"2024","journal-title":"Anesthesiology"},{"key":"R83-20260824","doi-asserted-by":"crossref","first-page":"e3168","DOI":"10.6061\/clinics\/2021\/e3168","article-title":"Early administration of fibrinogen concentrate in patients with polytrauma with thromboelastometry-suggestive hypofibrinogenemia: a randomized feasibility trial","volume":"76","author":"Lucena","year":"2021","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"R84-20260824","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajem.2021.12.033","article-title":"Effect of age on the efficacy of tranexamic acid: an analysis of heterogeneity of treatment effect within the CRASH-2 dataset","volume":"53","author":"Manoukian","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"5","key":"R85-20260824","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/TA.0000000000004516","article-title":"Association between prehospital tranexamic acid and cerebral edema in patients with moderate or severe traumatic brain injury","volume":"98","author":"McKinley","year":"2025","journal-title":"J Trauma Acute Care Surg"},{"issue":"10","key":"R86-20260824","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/acem.14745","article-title":"Pre-hospital freeze-dried plasma for critical bleeding after trauma: a pilot randomized controlled trial","volume":"30","author":"Mitra","year":"2023","journal-title":"Acad Emerg Med"},{"issue":"2","key":"R87-20260824","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcot.2018.04.011","article-title":"Effects of tranexamic acid on reducing blood loss in pelvic trauma: a randomized double-blind placebo-controlled study","volume":"10","author":"Monsef Kasmaei","year":"2019","journal-title":"J Clin Orthop Trauma."},{"issue":"10144","key":"R88-20260824","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(18)31553-8","article-title":"Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomized trial","volume":"392","author":"Moore","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"R89-20260824","first-page":"652","article-title":"Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: randomized clinical trial","volume":"70","author":"Morrison","year":"2011","journal-title":"J Trauma"},{"issue":"1","key":"R90-20260824","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13054-022-04167-x","article-title":"Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: laboratory sub-study of FEISTY","volume":"26","author":"Morrow","year":"2022","journal-title":"Crit Care"},{"issue":"1","key":"R91-20260824","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1574887114666191118111826","article-title":"Intravenous tranexamic acid for brain contusion with intraparenchymal hemorrhage: randomized, double-blind, placebo-controlled trial","volume":"15","author":"Mousavinejad","year":"2020","journal-title":"Rev Recent Clin Trials"},{"issue":"12","key":"R92-20260824","doi-asserted-by":"crossref","first-page":"E583","DOI":"10.1503\/cmaj.121986","article-title":"Fixed-ratio (1:1:1) transfusion protocol vs laboratory-guided transfusion in severe trauma: randomized feasibility trial","volume":"185","author":"Nascimento","year":"2013","journal-title":"CMAJ"},{"issue":"6","key":"R93-20260824","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/bja\/aew343","article-title":"Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial","volume":"117","author":"Nascimento","year":"2016","journal-title":"Br J Anaesth"},{"issue":"5","key":"R94-20260824","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/SLA.0000000000006640","article-title":"Early cold-stored platelet transfusion following traumatic brain injury: a randomized clinical trial","volume":"281","author":"Neal","year":"2025","journal-title":"Ann Surg"},{"issue":"4","key":"R95-20260824","first-page":"e958","article-title":"Effect of early tranexamic acid on bleeding, blood product consumption, mortality and length of stay in trauma with hemorrhagic shock: randomized clinical trial","volume":"62","author":"Negahi","year":"2021","journal-title":"J Prev Med Hyg"},{"key":"R96-20260824","doi-asserted-by":"crossref","first-page":"107709","DOI":"10.1016\/j.clineuro.2023.107709","article-title":"Effects of serum fibrinogen correction on outcome of traumatic cranial surgery: A randomized, single-blind, placebo-controlled clinical trial","volume":"229","author":"Niakan","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"R97-20260824","first-page":"1435","article-title":"TIC-TOC: a pilot randomized trial of tranexamic acid in children with traumatic injury","volume":"29","author":"Nishijima","year":"2022","journal-title":"Acad Emerg Med"},{"issue":"9771","key":"R98-20260824","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial","volume":"377","author":"Roberts","year":"2011","journal-title":"Lancet"},{"key":"R99-20260824","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajem.2020.12.082","article-title":"Pilot randomized trial of prehospital advanced therapies for hemorrhage control (PATCH) using pelvic binders","volume":"42","author":"Pierrie","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"4","key":"R100-20260824","first-page":"1088","article-title":"Effect of tranexamic acid on progression of hematoma in traumatic brain injury: a randomized controlled trial","volume":"33","author":"Rashid","year":"2024","journal-title":"Mymensingh Med J"},{"issue":"1","key":"R101-20260824","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/TA.0000000000002485","article-title":"Prehospital plasma in injured patients is associated with survival principally in blunt injury: results from two randomized prehospital plasma trials","volume":"88","author":"Reitz","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"key":"R102-20260824","doi-asserted-by":"crossref","first-page":"R178","DOI":"10.1186\/cc5133","article-title":"Recombinant activated factor VII as adjunctive therapy for bleeding control in severe trauma with coagulopathy: subgroup analysis from two randomized trials","volume":"10","author":"Rizoli","year":"2006","journal-title":"Crit Care"},{"issue":"6","key":"R103-20260824","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s13054-014-0685-8","article-title":"Mechanism of action of tranexamic acid in bleeding trauma patients: exploratory analysis of CRASH-2 data","volume":"18","author":"Roberts","year":"2014","journal-title":"Crit Care"},{"issue":"10","key":"R104-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: randomized controlled trial and economic evaluation of tranexamic acid in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"issue":"3","key":"R105-20260824","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/SHK.0000000000001073","article-title":"Risk factors for development of ARDS following hemorrhage","volume":"50","author":"Robinson","year":"2018","journal-title":"Shock"},{"issue":"4","key":"R106-20260824","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/TA.0000000000004354","article-title":"The effects of prehospital TXA on mortality and neurologic outcomes in patients with traumatic intracranial hemorrhage: a subgroup analysis from the prehospital TXA for TBI trial","volume":"97","author":"Rowell","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"R107-20260824","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jocn.2022.05.016","article-title":"Efficacy and safety of fibrinogen administration in acute post-traumatic hypofibrinogenemia in isolated severe TBI: randomized clinical trial","volume":"101","author":"Sabouri","year":"2022","journal-title":"J Clin Neurosci"},{"issue":"3","key":"R108-20260824","first-page":"183","article-title":"The effect of cryoprecipitate on prevention of intracerebral hemorrhage and brain contusion expansion in traumatic patients","volume":"14","author":"Saeidiborojeni","year":"2022","journal-title":"J Inj Violence Res"},{"issue":"2","key":"R109-20260824","first-page":"223","article-title":"Effect of intravenous tranexamic acid on intracerebral brain hemorrhage in TBI","volume":"31","author":"Safari","year":"2021","journal-title":"Turk Neurosurg"},{"issue":"4","key":"R110-20260824","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJMoa1802345","article-title":"Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock","volume":"379","author":"Sperry","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"R111-20260824","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SLA.0000000000006317","article-title":"Early cold stored platelet transfusion following severe injury: a randomized clinical trial","volume":"280","author":"Sperry","year":"2024","journal-title":"Ann Surg"},{"issue":"S1","key":"R112-20260824","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1111\/trf.16962","article-title":"Risk of thromboembolic events with early intravenous 2- and 4-gbolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: a secondary analysis of a randomized,double-blind, placebo-controlled, single-center trial","volume":"62","author":"Spinella","year":"2022","journal-title":"Transfusion"},{"key":"R113-20260824","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3389\/fimmu.2020.02085","article-title":"The immunologic effect of early intravenous two and four gram bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding (TAMPITI): a randomized, double-blind, placebo-controlled single-center trial","volume":"11","author":"Spinella","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"R114-20260824","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.rpth.2024.102568","article-title":"Hyperfibrinolysis: a crucial phenotypic abnormality of posttraumatic fibrinolytic dysfunction","volume":"8","author":"Takahashi","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"8","key":"R115-20260824","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.3390\/jcm9082420","article-title":"Dynamics of platelet counts in major trauma: the impact of haemostatic resuscitation and effects of platelet transfusion -A Sub-Study of the randomized controlled RETIC trial","volume":"9","author":"Tauber","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"R116-20260824","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/TA.0000000000001699","article-title":"The hyperfibrinolytic phenotype is the most lethal and resource-intense presentation of fibrinolysis in massive transfusion patients","volume":"84","author":"Taylor","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"issue":"7","key":"R117-20260824","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamasurg.2023.0819","article-title":"Association of trauma molecular endotypes with differential response to transfusion resuscitation strategies","volume":"158","author":"Thau","year":"2023","journal-title":"JAMA Surg"},{"issue":"8","key":"R118-20260824","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa2404360","article-title":"Liberal or restrictive transfusion strategy in patients with traumatic brain injury","volume":"391","author":"Turgeon","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"R119-20260824","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/TA.0000000000000960","article-title":"Damage-control resuscitation and emergency laparotomy: findings from the PROPPR study","volume":"80","author":"Undurraga-Perl","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"R120-20260824","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/XCS.0000000000000938","article-title":"Empiric cryoprecipitate transfusion in patients with severe hemorrhage: results from the US experience in the international CRYOSTAT-2 trial","volume":"238","author":"Van Gent","year":"2024","journal-title":"J Am Coll Surg"},{"issue":"3","key":"R121-20260824","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/TA.0000000000001357","article-title":"Damage control laparotomy utilization rates are highly variable among Level I trauma centers: Pragmatic, Randomized Optimal Platelet and Plasma Ratios findings","volume":"82","author":"Watson","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"R122-20260824","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-227X-13-20","article-title":"Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial","volume":"13","author":"Yutthakasemsunt","year":"2013","journal-title":"BMC Emerg Med."},{"issue":"4","key":"R123-20260824","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/EJA.0000000000001366","article-title":"Efficacy of prehospital administration of fibrinogen concentrate in trauma patients bleeding or presumed to bleed (FIinTIC): multicentre, double-blind, placebo-controlled randomized pilot","volume":"38","author":"Ziegler","year":"2021","journal-title":"Eur J Anaesthesiol"},{"issue":"76","key":"R125-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/JYTR6938","article-title":"Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis","volume":"28","author":"Curry","year":"2024","journal-title":"Health Technol Assess"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000004989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:00:41Z","timestamp":1787594441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000004989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000004989","relation":{},"ISSN":["2163-0755","2163-0763"],"issn-type":[{"value":"2163-0755","type":"print"},{"value":"2163-0763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"2025-11-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}